ReviewRenal failure2025

Cost-effectiveness of combining finerenone and sodium-glucose cotransporter 2 inhibitors with standard of care for patients with chronic kidney disease and type 2 diabetes in China.

Zhengqiang Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.